Medroxyprogesterone Acetate and Progesterone, Used Short Term, Do not Adversely Affect Forearm Reactive Hyperemia in Postmenopausal Women on Estradiol Therapy

Authors

MM Cho1,*, HN Hodis2, WJ Mack2, S Roy2, RJ Paulson2, Y Li2, FZ Stanczyk2
1Department of Obstetrics, Gynecology, and Womens Health, UMDNJ-New Jersey Medical School, [email protected], NJ
2Departments of Medicine and Preventive Medicine, Atherosclerosis Research Unit, USA
*Corresponding Author: Department of Obstetrics, Gynecology, and Womens Health, UMDNJ-New Jersey Medical School, [email protected], NJ. Email: [email protected]

International Journal of Endocrinology and Metabolism:Vol. 6, issue 2; 63-69
Published online:Apr 30, 2008
Article type:Research Article
Received:Jun 30, 2007
Accepted:Jan 02, 2008
How to Cite:Cho M, Hodis H, Mack W, Roy S, Paulson R, et al. Medroxyprogesterone Acetate and Progesterone, Used Short Term, Do not Adversely Affect Forearm Reactive Hyperemia in Postmenopausal Women on Estradiol Therapy. Int J Endocrinol Metab. 2008;6(2):. doi:

Abstract

This study aimed at investigating whet-her oral medroxyprogesterone acetate (MPA) or micronized progesterone (P) combined with micronized estradiol (E2) adversely affect endothelial function in postmenopausal women. Materials and Methods: Randomized, double-blind, crossover trial of MPA or micronized P with oral E2 treatment in menopausal women. Result: Flow-mediated, endothelium-dependent vasodilation of the brachial artery was not sig-nificantly affected by short-term administration of E2 alone or E2 combined with cyclic MPA, or E2 combined with cyclic P. Conclusion: Short-term oral E2 treatment of postmenopausal women alone or with cyclic oral MPA or oral P did not affect flow-mediated en-dothelium-dependent vasodilation.

Highlights

Full Text

Full text is available in PDF

Copyright

© 2008, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

25
Apr
2016

Association Between Depot-Medroxyprogesterone Acetate Injection and Periodontal Health in Reproductive Age Women: A Case Control Study in Iran

Firozeh Bagheri,
Mitra Tadayon,
Poorandokht Afshari,
Mahmoud Jahangirneghad,
Mohammad Hosein Haghighizadeh

Bagheri F, Tadayon M, Afshari P, Jahangirneghad M, Haghighizadeh MH. Association Between Depot-Medroxyprogesterone Acetate Injection and Periodontal Health in Reproductive Age Women: A Case Control Study in Iran. Jundishapur J Chronic Dis Care. 2016;5(3):e36922. doi: https://doi.org/10.17795/jjcdc-36922

31
Dec
2007

Evaluation of bleeding patterns in postmenopausal women under continuous or sequential hormone therapy

T Jahedbozorgan,
S Hasanzadeh

Jahedbozorgan T, Hasanzadeh S. Evaluation of bleeding patterns in postmenopausal women under continuous or sequential hormone therapy. J Inflamm Dis. 2024;11(3):e155340. doi:

31
Jan
2017

The Effects of Transdermal Estrogen Delivery on Bone Mineral Density in Postmenopausal Women: A Meta-analysis

Fatemeh Abdi,
Hamid Mobedi,
Farhad Bayat,
Nariman Mosaffa,
Mahrokh Dolatian,
Fahimeh Ramezani Tehrani

Abdi F, Mobedi H, Bayat F, Mosaffa N, Dolatian M, et al. The Effects of Transdermal Estrogen Delivery on Bone Mineral Density in Postmenopausal Women: A Meta-analysis. Iran J Pharm Res. 2017;16(1):e124928. doi: https://doi.org/10.22037/ijpr.2017.1967

30
Jun
2005

Evaluation of Mammographic Density Changes during Estrogen and Estrogen-Progesterone Therapy in Postmenopausal Women

Nasrin Ahmadinejad

Ahmadinejad N. Evaluation of Mammographic Density Changes during Estrogen and Estrogen-Progesterone Therapy in Postmenopausal Women. I J Radiol. 2005;2(3&4):e79101. doi:

11
Nov
2023
Micronized Progesterone or Dydrogesterone? A Comparative Study on the Effects of Two Forms of Progesterone on Pregnancy Outcomes After Threatened Abortion

Micronized Progesterone or Dydrogesterone? A Comparative Study on the Effects of Two Forms of Progesterone on Pregnancy Outcomes After Threatened Abortion

Iman Ansari,
Ezzatalsadat Hajiseid Javadi,
Hamideh Pakniat,
Ali Emami,
Fatemeh Ranjkesh,
Simindokht Molaverdikhani

Ansari I, Hajiseid Javadi E, Pakniat H, Emami A, Ranjkesh F, et al. Micronized Progesterone or Dydrogesterone? A Comparative Study on the Effects of Two Forms of Progesterone on Pregnancy Outcomes After Threatened Abortion. Iran J Pharm Res. 2023;22(1):e136320. doi: https://doi.org/10.5812/ijpr-136320

More by these authors

RJ PaulsonPubMedScholar
FZ StanczykPubMedScholar
Share
Cited by
Metrics